ALD

Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update

Retrieved on: 
Thursday, March 23, 2023

POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its results for the year ended December 31, 2022 and provided a corporate update.

Key Points: 
  • POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced its results for the year ended December 31, 2022 and provided a corporate update.
  • Based on recent sales trends, Sumitomo has increased its fiscal year 20223 forecast by 20% to JPY 1.8 billion6 (EUR 12.8 million)5.
  • For the Sumitomo fiscal year 2023 (ending March 31, 2024), as a conservative assumption, Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • Beyond 2024, Poxel expects to receive escalating double-digit royalties as well as additional sales-based payments upon achievement of contractually based sales thresholds.

Poxel Announces Cash Runway Extended Through Q2 2025 Based upon Debt Restructuring Agreement and New Equity-linked Financing Facility

Retrieved on: 
Thursday, March 23, 2023

With these agreements, assuming the full drawdown of the new equity-linked financing facility, the Company has extended its cash runway and expects to fund its operations and capital expenditure requirements through Q2 2025.

Key Points: 
  • With these agreements, assuming the full drawdown of the new equity-linked financing facility, the Company has extended its cash runway and expects to fund its operations and capital expenditure requirements through Q2 2025.
  • Based on the conservative forecast agreed upon by the Company and its lenders, amortization payments would be postponed until Q1 2025.
  • In addition, the agreement with IPF now offers more flexibility under the financial covenants, as detailed in the dedicated section below.
  • According to a schedule based on conservative TWYMEEG revenue projections, the Company expects the debt to be fully repaid in Q2 2029 at the latest.

Stellantis and Crédit Agricole Consumer Finance Joint Venture Plans to Acquire Activities of ALD in Portugal and LeasePlan in Luxembourg

Retrieved on: 
Wednesday, March 22, 2023

This announcement constitutes an immediate acceleration of the two companies’ ambitions in mobility and vehicle long-term leasing.

Key Points: 
  • This announcement constitutes an immediate acceleration of the two companies’ ambitions in mobility and vehicle long-term leasing.
  • This announcement follows the partnership agreements between Stellantis and Crédit Agricole Consumer Finance announced in December 2021 regarding the creation of a common NewCo, a European leader in long-term vehicle leasing, and the takeover by Crédit Agricole Consumer Finance of 100% of FCA Bank’s capital.
  • “Together, Leasys and Free2move Lease currently represent a fleet of approximately 828,000 vehicles.”
    Stellantis and Crédit Agricole Consumer Finance also announce the signing of an agreement relating to the sale of ALD’s activities in Ireland, Norway and Portugal, as well as LeasePlan’s activities in the Czech Republic, Finland and Luxembourg.
  • These disposals would take place according to the commitments made by ALD to the European Commission in connection with the proposed acquisition of LeasePlan by ALD.

Global ALD Equipment Market 2022 to 2028: Seamlessly Growing Semiconductor Industry Fuels Demand

Retrieved on: 
Thursday, March 2, 2023

The Global ALD Equipment Market size is expected to reach $6.5 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Key Points: 
  • The Global ALD Equipment Market size is expected to reach $6.5 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.
  • This is anticipated to fuel the expansion of the ALD equipment market since ALD makes it possible to deposit ultra-thin Nanolayers on a variety of substrates.
  • Therefore, the growth of the ALD equipment market is witnessing exponential growth due to the increasing demand for photovoltaics.
  • This factor is impeding the growth of the ALD equipment market.

Wheels, Donlen and LeasePlan Unite Under Wheels Brand Name

Retrieved on: 
Tuesday, February 28, 2023

DES PLAINES, Ill. and ALPHARETTA, Ga. and HAMILTON, Bermuda, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Following the previously announced LeasePlan USA and Wheels Donlen merger under Athene, the company today announced that they will brand the combined organization as Wheels.

Key Points: 
  • DES PLAINES, Ill. and ALPHARETTA, Ga. and HAMILTON, Bermuda, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Following the previously announced LeasePlan USA and Wheels Donlen merger under Athene, the company today announced that they will brand the combined organization as Wheels.
  • The new Wheels brand builds on the shared history of all three legacy organizations as leaders in fleet management and mobility, while leveraging the strong brand recognition of the Wheels name.
  • Each company has many contributions and history within the industry, always putting clients at the heart of everything they do.
  • Although the name Wheels remains, this is a New Wheels which builds upon:
    CEO Shlomo Crandus said: “We’re thrilled to unify our three organizations into one cohesive business under the new Wheels brand.

Anovion and Forge Nano Sign Offtake Agreement for the Supply of Synthetic Graphite Anode Powders Optimized With Atomic Armor™ for Next-Generation Lithium-Ion Batteries

Retrieved on: 
Tuesday, February 21, 2023

CHICAGO and DENVER, Feb. 21, 2023 /PRNewswire/ -- Anovion, an innovation-led, U.S.-based producer of battery materials with the mission of securing the domestic lithium-ion battery supply chain, and Forge Nano, Inc., a global leader in precision nano-coating technology, have signed an agreement for the supply of Anovion's American-made, commercial-scale synthetic graphite anode products with Forge Nano's proprietary Atomic Armor™ surface technology platform for next-generation anode materials.

Key Points: 
  • This agreement ensures security of supply for Forge Nano's graphite anode demand for their planned lithium-ion battery cell manufacturing.
  • "We are thrilled to be taking this next step in our partnership with Forge Nano," said Eric Stopka, Chief Executive Officer of Anovion.
  • Forge Nano and Anovion have already completed initial development work together and demonstrated that ALD coatings on Anovion graphite anode materials can deliver industry-leading performance.
  • "We are excited to be partnering with Anovion to create the highest performance synthetic graphite anodes available using Atomic Armor™," said Paul Lichty, CEO at Forge Nano.

Poxel Reports Cash and Revenue for the Full Year 2022 and Provides Corporate Update

Retrieved on: 
Wednesday, February 15, 2023

Thomas Kuhn, Chief Executive Officer of Poxel, stated: “We are very pleased with the most recent figures of TWYMEEG sales in Japan.

Key Points: 
  • Thomas Kuhn, Chief Executive Officer of Poxel, stated: “We are very pleased with the most recent figures of TWYMEEG sales in Japan.
  • For the Sumitomo fiscal year 2023 (ending March 31, 2024), as a conservative assumption Poxel expects to receive 8% royalties on TWYMEEG net sales.
  • In Q4 2022, Poxel initiated a corporate savings plan which includes a significant workforce reduction.
  • Full-Year Cash and Revenue ended December 31, 2022
    As of December 31, 2022, total cash and cash equivalents were EUR 13,1 million (USD 14 million)3, as compared to EUR 32,3 million at December 31, 2021 and EUR 17.1 million at September 30, 2022.

Azbil Launches New Sapphire Capacitance Diaphragm Gauges with MEMS Processing Technology to Enhance Resistance to Deposition

Retrieved on: 
Thursday, February 2, 2023

Azbil Corporation (TOKYO:6845) announced the availability as of January 25 of its model V8 sapphire capacitance diaphragm gauges, which employ MEMS*1 processing technology to enhance resistance to deposition*2 on the sensor.

Key Points: 
  • Azbil Corporation (TOKYO:6845) announced the availability as of January 25 of its model V8 sapphire capacitance diaphragm gauges, which employ MEMS*1 processing technology to enhance resistance to deposition*2 on the sensor.
  • Such a shift causes operators of film deposition and etching equipment to adjust the vacuum gauge more frequently, interfering with manufacturing plans.
  • In seeking a better solution, Azbil has thoroughly redesigned its current sapphire capacitance diaphragm gauge and released the model V8, which has a sensor with a new structure, flow path, etc.
  • MEMS technology is used to make the sensor chip’s surface uneven, helping to break up film deposited on the sensor diaphragm.

Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy

Retrieved on: 
Wednesday, January 25, 2023

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced that European Commission has granted orphan drug designation (ODD) for PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD).

Key Points: 
  • POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, today announced that European Commission has granted orphan drug designation (ODD) for PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD).
  • The decision follows a positive opinion from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).
  • The U.S. Food and Drug Administration has previously granted ODD and Fast Track Designation to both PXL770 and PXL065 for the treatment of ALD.
  • ODD in the European Union (EU) is granted by the European Commission based on a positive opinion issued by the European Medicines Agency (EMA) Committee for Orphan Medical Products (COMP).

Forge Nano Unveils New Brand Identity and Introduces Atomic Armor™, an Essential Technology to Revolutionize the Battery Market

Retrieved on: 
Friday, February 17, 2023

At the core of this new brand identity, Forge Nano has also introduced Atomic Armor™, the company's proprietary nanocoating technology that enables atomic level engineering and nanoscale surface engineering to build better materials.

Key Points: 
  • At the core of this new brand identity, Forge Nano has also introduced Atomic Armor™, the company's proprietary nanocoating technology that enables atomic level engineering and nanoscale surface engineering to build better materials.
  • Forge Nano has built a portfolio of equipment and tools to apply Atomic Armor™ onto nearly any surface and form factor.
  • With Atomic Armor™, Forge Nano is the only company delivering this innovative technology at commercial scale.
  • Elements of Forge Nano's new brand identity include:
    New Company and Brand Logos: The updated Forge Nano logo incorporates fresh, electric colors that reflect the company's bold vision for the future.